SG83672A1 - Methods of preventing breast cancer - Google Patents

Methods of preventing breast cancer

Info

Publication number
SG83672A1
SG83672A1 SG9703900A SG1997003900A SG83672A1 SG 83672 A1 SG83672 A1 SG 83672A1 SG 9703900 A SG9703900 A SG 9703900A SG 1997003900 A SG1997003900 A SG 1997003900A SG 83672 A1 SG83672 A1 SG 83672A1
Authority
SG
Singapore
Prior art keywords
methods
breast cancer
preventing breast
preventing
cancer
Prior art date
Application number
SG9703900A
Other languages
English (en)
Inventor
Jay Cohen Fredric
Ellen Glusman Joan
Keith Knickerbocker Ronald
Thomas Nickelsen Nikolaus
Janine Scott Teri
Stephen Eckert Robert
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27268608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG83672(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9624800.0A external-priority patent/GB9624800D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SG83672A1 publication Critical patent/SG83672A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG9703900A 1996-10-30 1997-10-29 Methods of preventing breast cancer SG83672A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2985096P 1996-10-30 1996-10-30
GBGB9624800.0A GB9624800D0 (en) 1996-11-29 1996-11-29 Methods of preventing breast cancer
US4026097P 1997-03-10 1997-03-10

Publications (1)

Publication Number Publication Date
SG83672A1 true SG83672A1 (en) 2001-10-16

Family

ID=27268608

Family Applications (2)

Application Number Title Priority Date Filing Date
SG9703900A SG83672A1 (en) 1996-10-30 1997-10-29 Methods of preventing breast cancer
SG1997003899A SG72765A1 (en) 1996-10-30 1997-10-29 Improvements in or relating to the prophylaxis of breast cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG1997003899A SG72765A1 (en) 1996-10-30 1997-10-29 Improvements in or relating to the prophylaxis of breast cancer

Country Status (44)

Country Link
US (2) US6303634B1 (et)
EP (3) EP0839532B1 (et)
JP (2) JPH10147530A (et)
CN (2) CN1182590A (et)
AP (1) AP971A (et)
AR (2) AR013864A1 (et)
AT (2) ATE338551T1 (et)
AU (3) AU5005697A (et)
BE (2) BE1011382A5 (et)
BG (1) BG63841B1 (et)
BR (1) BR9712703A (et)
CA (2) CA2219377A1 (et)
CH (2) CH693820A5 (et)
CZ (2) CZ300261B6 (et)
DE (2) DE69721692T2 (et)
DK (2) DK1369115T3 (et)
EA (2) EA002054B1 (et)
EE (1) EE03663B1 (et)
ES (4) ES2135343A1 (et)
FR (2) FR2755014B1 (et)
GB (3) GB2318734B (et)
GE (1) GEP20032910B (et)
GR (2) GR1003189B (et)
HK (1) HK1010495A1 (et)
HU (2) HUP9701777A3 (et)
IE (2) IE970773A1 (et)
IL (2) IL122026A0 (et)
IS (1) IS5035A (et)
IT (2) IT1298470B1 (et)
LU (2) LU90158B1 (et)
LV (1) LV12353B (et)
MY (1) MY121623A (et)
NL (2) NL1007386C2 (et)
NO (2) NO322468B1 (et)
NZ (1) NZ329042A (et)
PT (2) PT839532E (et)
RO (1) RO120813B1 (et)
SG (2) SG83672A1 (et)
SI (3) SI1369115T1 (et)
SK (1) SK287047B6 (et)
TR (1) TR199900951T2 (et)
UA (1) UA46762C2 (et)
WO (2) WO1998018325A1 (et)
YU (1) YU42397A (et)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
GB9624800D0 (en) * 1996-11-29 1997-01-15 Lilly Co Eli Methods of preventing breast cancer
FI109332B (fi) 1998-12-17 2002-07-15 Orion Yhtymae Oyj Toremifeenin liukoisia koostumuksia
FI982733A (fi) 1998-12-17 2000-06-18 Orion Yhtymae Oyj Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia
EP1401446B1 (en) 2001-05-22 2005-02-09 Eli Lilly And Company Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen
ES2259376T3 (es) 2001-05-22 2006-10-01 Eli Lilly And Company 1,2,3,4-tetrahidroquinolinas 2-sustituidas y sus derivados, composiciones y procedimientos.
US20040225200A1 (en) * 2003-05-09 2004-11-11 Edmundson Catherine M. System and method of analyzing the health of a population
GR1005694B (el) * 2005-06-08 2007-10-22 Αλεξης Μιχαηλ Ιστοειδικα αντιοιστρογονα ειδικα για τον αλφα υποδοχεα των οιστρογονων
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
MD23Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
MD35Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
MD36Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare
MD24Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
CN102973573B (zh) * 2012-11-28 2015-04-08 玉林师范学院 一种人乳腺癌细胞抑制剂及制备方法
CN103830197A (zh) * 2014-03-14 2014-06-04 崔书豪 一种盐酸雷洛昔芬分散片及其制备方法
CN116650484A (zh) * 2023-05-11 2023-08-29 南通大学 一种乳腺癌相关蛋白的抑制剂及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652004A1 (en) * 1993-10-15 1995-05-10 Eli Lilly And Company Methods for treating resistant neoplasms
EP0674903A1 (en) * 1994-03-02 1995-10-04 Eli Lilly And Company Raloxifene for inhibiting bone loss and lowing serum cholesterol
EP0680758A1 (en) * 1994-05-05 1995-11-08 Eli Lilly And Company Pharmaceutical compositions containing tamoxifen or analogs and raloxifene or analogs
WO1996022771A1 (en) * 1995-01-25 1996-08-01 Eli Lilly And Company Methods of inhibiting environmental estrogens

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4656187A (en) * 1981-08-03 1987-04-07 Eli Lilly And Company Treatment of mammary cancer
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
BR9500758A (pt) * 1994-03-02 1995-10-24 Lilly Co Eli Formulaçoes farmacêuticas para administraçao oral
US5821254A (en) 1995-02-17 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
CZ300341B6 (cs) * 1996-03-26 2009-04-22 Eli Lilly And Company Farmaceutická kompozice obsahující raloxifen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0652004A1 (en) * 1993-10-15 1995-05-10 Eli Lilly And Company Methods for treating resistant neoplasms
EP0674903A1 (en) * 1994-03-02 1995-10-04 Eli Lilly And Company Raloxifene for inhibiting bone loss and lowing serum cholesterol
EP0680758A1 (en) * 1994-05-05 1995-11-08 Eli Lilly And Company Pharmaceutical compositions containing tamoxifen or analogs and raloxifene or analogs
WO1996022771A1 (en) * 1995-01-25 1996-08-01 Eli Lilly And Company Methods of inhibiting environmental estrogens

Also Published As

Publication number Publication date
AR010538A1 (es) 2000-06-28
EP0839533A1 (en) 1998-05-06
ES2197312T3 (es) 2004-01-01
ITMI972434A1 (it) 1999-04-29
FR2755014B1 (fr) 1999-02-05
EP1369115B1 (en) 2006-09-06
ES2135342A1 (es) 1999-10-16
EP1369115A1 (en) 2003-12-10
CZ341197A3 (cs) 1998-05-13
GB2318733A (en) 1998-05-06
BE1011381A5 (fr) 1999-08-03
HUP9701777A3 (en) 1999-07-28
DE69721692T2 (de) 2004-03-25
ES2271476T3 (es) 2007-04-16
CH691847A5 (fr) 2001-11-15
NO974972D0 (no) 1997-10-28
IL122026A0 (en) 1998-03-10
IL122025A (en) 2003-01-12
SK287047B6 (sk) 2009-10-07
IL122025A0 (en) 1998-03-10
GB9722796D0 (en) 1997-12-24
DE69736644T2 (de) 2007-10-25
GR970100409A (el) 1998-06-30
AR013864A1 (es) 2001-01-31
CA2219070A1 (en) 1998-04-30
YU42397A (sh) 2000-10-30
FR2756490A1 (fr) 1998-06-05
NO322468B1 (no) 2006-10-09
CZ341297A3 (cs) 1998-05-13
PT1369115E (pt) 2006-12-29
GB2318734B (en) 1999-12-01
ATE338551T1 (de) 2006-09-15
FR2756490B1 (fr) 2003-06-20
UA46762C2 (uk) 2002-06-17
NL1007387C2 (nl) 1998-05-14
IT1298470B1 (it) 2000-01-10
SI20107A (sl) 2000-06-30
DE69721692D1 (de) 2003-06-12
EP0839532B1 (en) 2003-05-07
DK1369115T3 (da) 2007-01-02
GB2318734A (en) 1998-05-06
EA006083B1 (ru) 2005-08-25
ATE239475T1 (de) 2003-05-15
NL1007386C2 (nl) 1998-05-14
BG103369A (en) 2000-05-31
ES2135343A1 (es) 1999-10-16
US6303634B1 (en) 2001-10-16
EA199900431A1 (ru) 1999-10-28
BE1011382A5 (fr) 1999-08-03
JPH10147530A (ja) 1998-06-02
AP971A (en) 2001-05-30
BG63841B1 (bg) 2003-03-31
BR9712703A (pt) 1999-10-26
AU4364897A (en) 1998-05-07
EA002054B1 (ru) 2001-12-24
GB9911557D0 (en) 1999-07-21
EE03663B1 (et) 2002-04-15
SI0839532T1 (en) 2003-10-31
LV12353B (en) 2000-02-20
AU5005197A (en) 1998-05-22
LU90158B1 (fr) 1998-06-02
MX9708340A (es) 1998-08-30
TR199900951T2 (xx) 1999-07-21
NZ329042A (en) 1999-08-30
MX9708341A (es) 1998-08-30
CN1182590A (zh) 1998-05-27
AU4364797A (en) 1998-05-07
EA200100716A1 (ru) 2002-06-27
US20020019418A1 (en) 2002-02-14
NO974972L (no) 1998-05-04
GEP20032910B (en) 2003-03-25
CH693820A5 (fr) 2004-02-27
AU731388B2 (en) 2001-03-29
IE970773A1 (en) 2000-02-09
SK55999A3 (en) 2000-06-12
FR2755014A1 (fr) 1998-04-30
SI1369115T1 (sl) 2006-12-31
CA2219377A1 (en) 1998-04-30
DE69736644D1 (de) 2006-10-19
HU9701777D0 (en) 1997-12-29
HU9701778D0 (en) 1997-12-29
JPH10147529A (ja) 1998-06-02
HK1010495A1 (en) 1999-06-25
AP9901494A0 (en) 1999-03-31
GR1003189B (el) 1999-09-01
LU90157B1 (fr) 1998-06-02
ITMI972433A1 (it) 1999-04-29
EE9900162A (et) 1999-12-15
ES2135342B1 (es) 2000-05-16
CA2219070C (en) 2007-12-18
LV12353A (lv) 1999-10-20
WO1998018449A1 (en) 1998-05-07
CZ300261B6 (cs) 2009-04-01
RO120813B1 (ro) 2006-08-30
IS5035A (is) 1999-04-27
PT839532E (pt) 2003-09-30
HUP9701778A2 (hu) 1999-01-28
IE970772A1 (en) 2000-02-09
GR970100408A (el) 1998-06-30
DK0839532T3 (da) 2003-08-25
NO974973D0 (no) 1997-10-28
SG72765A1 (en) 2000-05-23
MY121623A (en) 2006-02-28
AU5005697A (en) 1998-05-22
EP0839532A1 (en) 1998-05-06
HUP9701778A3 (en) 1999-06-28
WO1998018325A1 (en) 1998-05-07
GB9722801D0 (en) 1997-12-24
HUP9701777A2 (hu) 1999-06-28
CN1182591A (zh) 1998-05-27

Similar Documents

Publication Publication Date Title
GB2318734B (en) Methods of preventing breast cancer
ZA982968B (en) Compositions and methods for the treatment and diagnosis of breast cancer
AU8259798A (en) Method for detection of breast cancer
GB9509572D0 (en) Cancer therapy
AU8068198A (en) Methods for treating human cancers
IDP000008233A (id) Metode pencegahan kanker payudara
MD798F1 (en) Method of the mamma cancer treatment
GB9620350D0 (en) Cancer vaccine
GB9703633D0 (en) Cancer therapy
GB9819999D0 (en) Treatment of cancer
IL115022A0 (en) Methods of inhibiting endometrial cancer
GB9624800D0 (en) Methods of preventing breast cancer
AU731388C (en) Methods of preventing breast cancer
ZA992858B (en) Methods of preventing breast cancer.
GB9804361D0 (en) Cancer treatment
GB9903035D0 (en) Treating cancer
HU9801868D0 (en) Droloxifene for prevention of breast cancer
GB2334579B (en) Treating cancer
GB9617941D0 (en) New approach to the treatment of prostate cancer
GB9424578D0 (en) Cancer treatment
GB9802420D0 (en) Skin cancer alleviator
IL120901A0 (en) Cancer therapy
GB9701876D0 (en) Cancer therapy
TW358610U (en) Improvement of inter-com
TW358506U (en) Combiantion of air-inflated shield